Moderna has tapped Wilmer Cutler Pickering Hale and Dorr for an explosive patent infringement suit against Pfizer and BioNTech over the mRNA technology behind the COVID-19 vaccine, bringing in a name familiar to the parties on both sides of the dispute.
While the firm has previously represented Moderna in patent litigation, Wilmer partner Bill Lee, the lead lawyer on the complaint filed in Massachusetts federal court Friday morning, has a history representing Pfizer. In 2013, Lee, a former co-managing partner at Wilmer, led Pfizer to a $2.15 billion patent infringement settlement with generic drug makers.
This content has been archived. It is available through our partners, LexisNexis® and Bloomberg Law.
To view this content, please continue to their sites.
LexisNexis® and Bloomberg Law are third party online distributors of the broad collection of current and archived versions of ALM's legal news publications. LexisNexis® and Bloomberg Law customers are able to access and use ALM's content, including content from the National Law Journal, The American Lawyer, Legaltech News, The New York Law Journal, and Corporate Counsel, as well as other sources of legal information.
For questions call 1-877-256-2472 or contact us at [email protected]